Use of immunomodulatory therapy as part of comprehensive treatment of non-severe community-acquired pneumonia and its long-term results

Mikhail P Kostinov, Vilia V Gainitdinova, Svetlana V Kazharova, Anna E Vlasenko, Vflentina B Polishchuk, Kirill V Mashilov

Article Type

Original Research

Published

This work aims to study the effectiveness of two different types of immunomodulators for the treatment of non-severe community-acquired pneumonia and assesses the long-term effects of the treatment conducted.

Read more

Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Luydmila Yu Akhieva, Elena V Kuntsevich, Anastasia A Troshina, Elena I Kvasova, Anton A Tikhonov, Nadezhda F Khomyakova, Francisco Harrison, Jean-François Rossi, Timothy C Hardman

Article Type

Original Research

Published

This study evaluated the safety and efficacy of azoximer bromide when used in combination with standard of care treatment in patients hospitalized with COVID-19.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.